A New Paradigm for MAPK: Structural Interactions of hERK1 with Mitochondria in HeLa Cells by Galli, Soledad et al.
A New Paradigm for MAPK: Structural Interactions of









6, Juan Jose Poderoso
7, Elizabeth A. Jares-Erijman
2, Thomas M. Jovin
1,8*
1Laboratory of Cellular Dynamics, Max Planck Institute for Biophysical Chemistry, Go ¨ttingen, Germany, 2Departamento de Quı ´mica Orga ´nica, Facultad de Ciencias
Exactas y Naturales (FCEyN), Universidad de Buenos Aires (UBA), CIHIDECAR, CONICET, Buenos Aires, Argentina, 3Proteomics Group, Max Planck Institute of Experimental
Medicine, Go ¨ttingen, Germany, 4Deutsche Forschungsgemeinschaft Research Center for Molecular Physiology of the Brain, Go ¨ttingen, Germany,
5Transkriptomanalyselabor, University of Go ¨ttingen, Zentrum 3, Biochemistry and Molecular Cell Biology, Go ¨ttingen, Germany, 6Bioanalytical Mass Spectrometry
Group, Max Planck Institute for Biophysical Chemistry, Go ¨ttingen, Germany, 7Laboratory of Oxygen Metabolism, University Hospital ‘‘Jose de San Martin’’, UBA, Buenos
Aires, Argentina, 8Laboratorio Max Planck de Dina ´mica Celular, FCEyN, UBA, Buenos Aires, Argentina
Abstract
Extracellular signal-regulated protein kinase 1 and 2 (ERK1/2) are members of the MAPK family and participate in the
transduction of stimuli in cellular responses. Their long-term actions are accomplished by promoting the expression of
specific genes whereas faster responses are achieved by direct phosphorylation of downstream effectors located
throughout the cell. In this study we determined that hERK1 translocates to the mitochondria of HeLa cells upon a
proliferative stimulus. In the mitochondrial environment, hERK1 physically associates with (i) at least 5 mitochondrial
proteins with functions related to transport (i.e. VDAC1), signalling, and metabolism; (ii) histones H2A and H4; and (iii) other
cytosolic proteins. This work indicates for the first time the presence of diverse ERK-complexes in mitochondria and thus
provides a new perspective for assessing the functions of ERK1 in the regulation of cellular signalling and trafficking in HeLa
cells.
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Introduction
ERK1 and ERK2 are members of the MAPK family of
signalling proteins and play key roles in the transduction of
extracellular stimuli into cellular responses [1,2]. Induction of this
signalling cascade leads to the phosphorylation of several target
proteins that regulate cellular fate and other physiological
processes [3]. The ultimate effects of ERK1/2 activation are
determined by the phosphorylation of its downstream effectors
located in the cytoplasm and nucleus, as well as in other cellular
compartments. Indeed, the ubiquitous nature of ERK1/2 action is
reflected in an ever-expanding list of ERK1/2 substrates [1–5].
The long-term actions of ERK1/2 are accomplished by promoting
the expression of genes under the control of specific transcription
factors, including Elk-1, Myc, Myb and the cAMP-response
element. Activation of gene expression is preceded by the
translocation of activated ERK1/2 from the cytoplasm to the
nucleus [6,7]. ERK1 and 2 are coexpressed in most tissues, are
very similar in sequence and have been generally thought to be
interchangeable. While recent evidence suggests that the ERK
kinases are not functionally redundant and may have very different
roles [see 8 for review], further studies are needed to assess the
interplay between the two proteins and its effects on signalling
dynamics. Increasing evidence suggests the existence of non-
genomic effects of ERK. Shaul and Seger [4] showed that an
alternative splice variant of ERK1 can participate in Golgi
fragmentation during mitosis, while Klemke et al. [9] demonstrated
that ERK phosphorylates myosin light chain kinase, a critical step
in the regulation of myosin light chain function in contractility and
cell migration. Poderoso et al. [5] observed that ERK1/2
activation by cAMP results in maximal steroidogenic rate.
ERK is present in mitochondria. Alonso et al. [10] reported the
existence of ERK1/2 in the outer membrane and intermembrane
space of brain mitochondria. The translocation of ERK1/2 to brain
mitochondria follows a developmental pattern, peaking at stages
E19-P2 and decreasing from P3 to adulthood. Baines et al. [11] have
shown the presence of ERK in murine heart mitochondria and a
PKCe-ERK module appears to play a role in PKCe-mediated
cardioprotection. Poderoso et al. [5] reported the presence of
ERK1/2 in the mitochondria of Leydig-transformed MA-10 cell
line, and concluded that mitochondrial ERK activation was
obligatory for PKA mediated steroidogenesis. Finally, Galli et al.
[12] observed that ERK as well as p38, JNK and their respective
MAPKKsarepresentinthemitochondriaofatumoralcellline,and
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7541furthermore that the traffic of these MAPKs in and out of the
organelle is regulated by hydrogen peroxide. Although definite
functional consequences of ERK localization in mitochondria have
not been reported previously, one must consider that phospho-
ERK1/2 may regulate mitochondrial activities related to cellular
survival and metabolism. In the complex molecular infrastructure
that underlies the mechanisms of activation and transduction, ERK
orchestratesaseriesofsignallingeventsthatresultintherecruitment
of many downstream factors, including kinases, transcription
factors, and other proteins. ERK present in mitochondria would
be expected to form protein complexes involved in regulation of
mitochondrial metabolism. Thus, identification of interaction
partners of ERK in the organelle may provide important insights
into the molecular basis of its putative role as a mitochondrial
regulator.
Protein dimerization is common to numerous mechanisms
for the transduction of extracellular signals. Phosphorylation of
ERK2 facilitates its dimerization in vitro. By equilibrium
sedimentation, Khokhlatchev et al. [13] determined that phos-
phorylated ERK2 sediments primarily as an 84 kDa species,
whereas unphosphorylated ERK2 migrates as a mixture of a
lesser fraction of 84 kDa and a predominant fraction of a 42 kDa
species. A model of dimerized kinase deduced from the crystal
structure of phosphorylated ERK2, proposes the physical basis
for dimerization [14]. Phosphorylation leads to conformational
changes in the two flexible regions of the protein molecule, the
activation loop and the C-terminal extension, thereby generating
the molecular interfaces for homodimerization. The two ERK2
molecules bind via a hydrophobic zipper complemented by two
ion pairs, one on each side of the zipper [for reviews, see 15 and
16]. ERK2 also dimerizes when transfected or microinjected into
cells, but the process requires its phosphorylation [13]. Whether
dimerization is necessary for nuclear localization remains
controversial; some authors have observed an enhanced nuclear
translocation upon phosphorylation of the kinase [13]. However,
Lidke et al. (unpublished data of our laboratory) have determined
that ERK mutants unable to dimerize retain the ability to
translocate to the nucleus, albeit at a slower rate. Casar et al.[ 1 7 ]
have recently demonstrated that scaffold proteins and ERK
dimers are essential for the activation of cytoplasmic but not of
nuclear substrates. Dimerization is critical for connecting the
scaffolded ERK complex to cognate cytoplasmic substrates. In
contrast, nuclear substrates associate with ERK monomers.
Philipova and Whitaker [18] showed that ERK1 is capable of
dimerizing both in vivo and in vitro. Dimerization in vitro of the
human recombinant protein requires both ERK1 phosphoryla-
tion and the intervention of cellular cofactors. Exposure of the
resultant high molecular weight complex to b-mercaptoethanol
(b-ME) leads to dissociation. In view of the ambiguous structural
and cell biological evidence for the existence and significance of
dimerization, further investigation of the role of dimerization in
the regulation of ERK trafficking under different cellular
conditions is required.
The genome of animal mitochondria (mtDNA) encodes a small
number of proteins, all of which are required for electron transport
and oxidative phosphorylation, and the RNAs required for the
translation machinery, i.e., two rRNAs and 22 tRNAs. The
majority of the organelle proteins, including a large number of
subunits of the electron transport complexes and the totality of the
ribosomal proteins, are specified by nuclear genes [19]. Thus, the
contributions of both the nuclear and mitochondrial genomes are
required for maintaining functional oxidative phosphorylation, an
appropriate balance of ribosomes and mRNAs, as well as intrinsic
mitochondrial functions such as the synthesis of heme, purines and
Fe-S clusters. From this perspective, the regulation of mtDNA
transcription is an issue of major importance.
In the present study, we adopted a functional proteomic
approach to gain insights into ERK-dependent signalling in
mitochondria of HeLa cells. While both ERK1 and 2 are found in
mitochondria, we focused our attention in this initial study on
ERK1. We determined that ERK1 forms signalling complexes in
the organelle and identified the components of these complexes.
These proteins participate in multiple physiological pathways such
as lipid metabolism, oxidative balance and anion transport. In
addition, ERK interacts with histones and these nuclear proteins
are present in the OMM of HeLa cells. We also evaluated the
nature of ERK dimerization, and the role of the mitochondrion in
this process. Finally, we assessed the potential role of ERK in the
modulation of HeLa mitochondrial gene expression.
Results
Purity and integrity of the mitochondrial fraction
The procedures for the isolation of mitochondria from HeLa
cells and the evaluation of purity are provided in the supporting
online material (Fig. S1, Table S1 and Supporting Information
S1). The mitochondrial preparations were intact according to
standard criteria for assessing structural, morphological and
functional integrity.
Presence and translocation of hERK1 into cellular and
isolated mitochondria
In this work we demonstrated the presence of endogenous and
recombinant hERK1 in purified non-contaminated mitochondria
of HeLa cells. HeLa cells were transfected with hERK1-GFP and
further stained with a specific mitochondrial marker, MitoTracker
RED CMXRos, and analyzed by confocal microscopy. Approx-
imately 15% of the hERK1-GFP molecules localized in mito-
chondria, 30% in the nuclear compartment and the rest were
distributed in cytosol in 24 h serum starved HeLa cells (Fig. 1,
A–C). Mitochondrial hERK1-GFP content was greatly reduced in
the organelles of not serum deprived cells (Fig. S2). Stimulation
with fetal calf serum (FCS) led to a redistribution of hERK1-GFP
among the different subcellular compartments (Fig. 1, A–F and
Movie S1). The predominant effect was a net import of ERK into
the nucleus with the corresponding depletion of the cytosolic pool.
An additional early event was the entry of ERK into mitochon-
dria, followed by an exit synchronized with the translocation to the
nucleus (Fig. 1, A–F and Movie S1). The interdependence of
nuclear and mitochondrial ERK was revealed by analysis of the
slopes of the redistribution curves during 7–20 min (Fig. 1B). The
rate of ERK entry into the nuclear compartment (0.5% of initial
value/min) was approximately equal to the sum of ERK depletion
from the mitochondria and cytosol (20.5 and 20.1%/min,
respectively). No hERK1 redistribution was observed in the
absence of FCS stimulation (Fig. S3, and Movie S2). We did not
observe a similar redistribution of GFP protein in HeLa cells
under the same conditions (Fig. S4). Several reports show that after
cellular starvation ERK1/2 are responsive to proliferative stimuli
[12,20], including the addition of FCS (Lidke et al., unpublished
data of our laboratory). However, response to these stimuli is
abrogated in cells under normal culture conditions favoring
proliferation (data not shown).
We evaluated the colocalization indexes of the hERK1-GFP
and MitoTracker images within the mitochondrial mask either in
24 h FCS deprived HeLa, or in cells grown in complete media
(10% FCS); and the change in Pearson’s correlation coefficient
upon FCS stimulation of 24 h starved cells (Fig. 1, D–E; for details
ERK1-Mitochondria Interaction
PLoS ONE | www.plosone.org 2 October 2009 | Volume 4 | Issue 10 | e7541Figure 1. Presence and translocation of hERK1 into mitochondria. (A) HeLa cells transfected with hERK1-GFP, 24 h FCS starved and stained
with MitoTracker CMXRos were stimulated with 10% FCS and fluorescence intensity of both green (GFP) and red (MitoTracker) channels was followed
for 20 min in an Olympus FV1000 confocal microscope. Images of four representative time points after FCS stimulation of the individual and merged
channels are shown. Bar=10 mm. (B) Changes in hERK1-GFP fluorescence intensity after FCS stimulation analyzed in mitochondria, nuclei and cytosol
for each of the 8 confocal planes analysed for the pair of images in A. Graphs show the net change displayed as percentage of the initial value (% of
control) in each compartment after FCS stimulation. (C) Redistribution of hERK1-GFP fluorescence intensity in the different cellular compartments
upon FCS stimulation. (D) Change in Pearson’s correlation coefficient after FCS stimulation of serum starved cells analyzed within the mitochondrial
mask. (E) Colocalization coefficients for HeLa cells FCS starved or cultured in 10% FCS. The. M and C coefficients were calculated only for red images.
Manders Overlap=Manders Overlap coefficient. (F) hERK1-GFP and MitoTracker intensity correlation plots 0 and 20 min after FCS stimulation. Color
bar=number of pixels. (G) HeLa cells transfected with hERK1-Dronpa, stained with MitoTracker Deep Red and washed in 0.1% Triton X-100 buffer
(lower panel). An image of the individual and merged channels is shown compared to non-Triton washed cells (upper panel). (H) Isolated
mitochondria from serum starved HeLa cells (lower panel) or cells cultured in 10% FCS (upper panel). Cells were labelled with MitoTracker Deep Red
and further fixed and immuno-stained for phospho-ERK. Secondary antibody was conjugated to Cy3. An image of the individual and merged
channels is shown for each case. (I) Western blot of different HeLa cellular fractions probed against ERK1/2. C=cytosol, M=mitochondria, N=nuclei.
(J) Mitochondria from HeLa incubated with hERK1 recombinant protein in an import assay, and analyzed by western blotting. Loading control,
antibody to a mitochondrial complex 1 subunit.
doi:10.1371/journal.pone.0007541.g001
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therein). The coefficients M and C were unity, indicating that the
totality of the pixels enclosed by the mitochondrial mask contained
hERK1-GFP (Fig. 1E). The Pearson’s correlation coefficient
decreased after FCS stimulation as ERK moved out of the
organelle (compare Fig. 1B, lower panel and D). The diminished
correlation between hERK1-GFP and MitoTracker fluorescence
upon FCS stimulation was also observed in the intensity
correlation plots in figure 1F. At time 0, most of the pixels
displayed both green and red fluorescence intensities; upon
stimulation the diagonal was lost and pixels were located along
the hERK1-GFP axis with only a few pixels with high red
fluorescence intensity and variable GFP intensity. We evaluated
the significance of the Pearson’s correlation coefficient of hERK1-
GFP and MitoTracker RED CMXRos images according to
previously reported procedures [21]. The value was significant,
arguing for true colocalization instead of a fortuitous superposition
of randomly distributed fluorophores (Fig. S5 and Supporting
Information S1). The Pearson’s correlation coefficient for HeLa
cells grown continuously in 10% FCS was negative (Fig. 1E),
indicating a lack of colocalization.
To demonstrate unequivocally the presence of hERK1 in HeLa
mitochondria, we transfected cells with hERK1-Dronpa and
labelled with MitoTracker Deep Red. The cells were washed with
0.1% Triton X-100 to eliminate cytosolic ERK. We observed
hERK1-Dronpa in the mitochondria even after the Triton wash
(Fig. 1G).
Endogenous ERK1/2 was also present in the mitochondria of
HeLa cells (Fig. 1, H–I). We incubated isolated mitochondria with
MitoTracker Deep Red and fixed and labelled them with an
antibody against phospho-ERK1/2 and a second antibody
conjugated with Cy3. Confocal microscopy revealed that phos-
phorylated ERK1/2 was present in the mitochondria (Fig. 1H).
Indeed, we determined a 3-fold increase in the signal of phospho-
ERK1/2 in 24 h serum deprived cells prior to mitochondria
isolation compared to non-serum starved cells (fluorescence
intensity in arbitrary units: 4306120 vs. 90645, n=15 and
n=32, respectively, p,0.05, Student’s t test). The presence of
endogenous ERK1/2 in the mitochondria was corroborated by
western blotting (Fig. 1I; see Fig. 1S for mitochondrial purity and
fractionation markers). In addition, incubation of mitochondria
with the recombinant protein hERK1 in an import assay led to
entry of the protein into the organelle (Fig. 1J).
The above findings are consistent with the report of Galli et al.
[12] of a redistribution of ERK1/2 and recombinant ERK2
between the subcellular compartments of a lung cancer cell line,
LP07, upon stimulation with H2O2. Altogether, these data strongly
suggest that upon proliferative stimulation, ERK1 translocation to
the nucleus ensues from both the mitochondrial and cytosolic
pools of the kinase.
hERK1 interaction with the mitochondrial proteome
The presence of ERK in mitochondria and the response to
serum growth factors argue for a putative regulatory role of
ERK1/2 in mitochondrial metabolism and we addressed this issue
by means of interaction assays of GST-hERK1 recombinant
protein on pure mitochondrial preparations, followed by proteo-
mic analysis. Mitochondrial extracts were incubated with GST-
hERK1 or GST-null recombinant proteins and extensively
washed. The complexes were resolved by SDS-PAGE under
denaturing conditions and Coomasie stained (Fig. 2). Most of the
bands appeared in the GST-hERK1 lane, attesting to the
specificity of the interaction. In every case, a band in the GST-
null lane was taken as a control. Only proteins that appeared in
the GST-hERK1 but not in the GST-null lanes were considered
to be specific ERK interactors. We detected the formation of
complexes with several mitochondrial proteins, described in
Table 1, Table S2, in the following sections and in the
supplemental online material.
Transport proteins
Porin 31HL or VDAC1 (voltage-dependent anion channel 1) is
a 31 kDa protein comprised of one polypeptide chain with
hydrophobic and hydrophilic domains [22]. It is the major
transport protein of the OMM [23]. Monomeric VDAC serves
itself as a functional channel [24]. However, there is evidence that
it can form dimers and possibly tetramers [25,26], and that this
oligomerization may be involved in mitochondrial mediated
apoptosis [25,27]. The OMM provides a barrier between the
mitochondrial inner membrane and cytoplasm and VDAC
mediates the complex interactions between mitochondria and
other parts of the cell by transporting anions, cations, ATP, Ca
2+
and metabolites. Thus, VDAC plays an important role in the
coordination of communication between mitochondria and
Figure 2. hERK1-GST pulldown assay. GST-hERK1 or GST-null
recombinant proteins immobilized on GSH-agarose were
incubated overnight with a mitochondrial extract. Beads were
extensively washed and eluted proteins were run on SDS-PAGE.
Proteins were stained with Coomasie Brilliant Blue G-250. Molecular
weight markers displayed on the left. GST-hERK1 and GST-null
recombinant proteins highlighted on the right. Numbers on the right
side of the bands recovered in GST-hERK lane represent proteins
identified by mass spectrometry and shown in Table 1.
doi:10.1371/journal.pone.0007541.g002
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with other proteins is an essential feature. Although the
mechanism remains elusive, several hypotheses have been
proposed [26–30].
Mass spectrometric protein identification revealed an interac-
tion of hERK1 with VDAC1 in mitochondria (Fig. 2 and Table 1).
We observed an extensive colocalization of hERK1-GFP with
VDAC in HeLa cells (Fig. 3A). Greater than 80% of pixels in the
cell contained fluorescence in both channels (Cgreen and Cred), and
Pearson’s correlation coefficient was almost 1 (Fig. 3C). We
corroborated hERK1 and VDAC1 interaction by confocal
microscopy utilizing FRET (Fo ¨rster Resonance Energy Transfer)
between hERK1-GFP transfected into HeLa cells and Cy3-
conjugated secondary antibody used to immuno-localize VDAC1
with a specific primary antibody. The mean FRET efficiency
between these two molecules in the cytoplasm was 0.3 and the
energy transfer was largely confined to the perinuclear zone (Fig. 3,
A and D). The interaction also occurred in intact cells, a finding
established by fixing and labelling cells with primary antibodies
against phospho-ERK1/2 and VDAC1 and secondary antibodies
conjugated to Cy5 and Cy3, respectively, and conducting
comparative FRET experiments. Energy transfer was observed
supporting the idea of an interaction between these molecules in
cytoplasm and nuclei, but mainly in the perinuclear zone (Fig. 3, B
and E). Little FRET was apparent in the negative control although
some unspecific Cy5 signal was present.
The mitochondrial network is disposed primarily in the
perinucelar region. Our findings support the notion that ERK1
may translocate to and from the organelle through the VDAC
channel, a possibility that deserves further study as it could
constitute a mechanism for the regulation of ERK availability to
the nucleus, and thus its influence on cell fate.
VDAC1Ser 104isembedded ina minimal phosphorylation motif
for ERK(Ser/Thr-Pro) [31],and thus mayserve asa putative target
for ERK1 phosphorylation. In addition, the study of VDAC amino
acid sequence shows that the molecule has a potential ERK docking
domain (Fig. S6) [32,33]. If ERK1 can bind and phosphorylate
VDAC,itcould regulate channelactivity by modulating the traffic of
metabolites between mitochondria and cytosol.
Structural proteins
Using MALDI-TOF-MS, we identified histones H2A and H4 as
binding partners of ERK in five out of five pulldown assays
performed (Table 1 and Fig. 2). These results were confirmed by
LC-MS/MS, a complementary approach for protein identifica-
tion. We then determined whether these proteins were truly
integrated into mitochondria, or merely attached to the OMM. By
flow cytometry we observed the presence of H2A and H4 in the
mitochondrial fraction, either with or without permeabilization of
the mitochondrial membrane, a result compatible with a
superficial distribution of histones on the organelle (Fig. S7, A).
Negative controls were performed with mitochondria alone or
stained with Cy5 in the absence of primary antibodies. Both
yielded negative results, with a fluorescence intensity mean lower
than 6. By western blotting we detected the presence of histones in
the mitochondrial fraction, but these proteins were removed after
treatment of mitochondria with proteinase K, further supporting a
localization of the proteins in the OMM (Fig. S7, B). We observed
extensive colocalization throughout the cell of hERK1-GFP and
H2A or H4; 85–90% of the pixels inside the cell contained
fluorescence intensity in both channels and Pearson’s correlation
coefficient was 0.99 for H4 and almost 0.9 for H2A (Fig. 4, A–B).
We corroborated the interaction of hERK1 with H2A and H4 by
pulldown of GST-hERK1 and immuno-staining of histones
(Fig. 4D) and observed a FRET efficiency of almost 0.2 and 0.3
between hERK1-GFP and H4 or H2A, respectively, in the nuclei
of HeLa cells, with a somewhat lower in the cytoplasm (Fig. 4C).
To asses whether these biochemical interactions occurred in intact
cells, we conducted comparative FRET experiments in HeLa
labelled with antibodies to phospho-ERK1/2 and H2A or H4 and
secondary antibodies conjugated to Cy3 and Cy5, respectively.
The mean FRET efficiency was 0.17 for the ERK-H2A
interaction and 0.14 for the ERK-H4 interaction. The former
value was significantly greater than that of the specificity control
(0.12, HeLa cells labelled against phospho-ERK1/2 plus both
secondary antibodies), and both interactions were significantly
greater than in the negative control (Fig. 5, HeLa cells labelled
against phospho-ERK1/2 plus Cy3).
BothH2A and H4have Serand Thr in their sequence, but none of
them is present ina canonical ERK phosphorylation motif. However,
S e r2i nH 2 A ,a n dS e r2a n dS e r4 8i nH 4a r ef o l l o w e db yag l y c i n e ,
motif that has also been reported to be recognised and phosphor-
ylated by ERK [33]. In addition, both H2A and H4 amino acid
sequences display putative ERK docking domains (Fig. S6) [32,33].
ERK dimerization
As stated earlier, ERK1 forms homodimers [13,14,19], and we
confirmed the presence of dimers inside mitochondria. After
Table 1. hERK1 signaling complexes in mitochondria from HeLa cells.
MW (kDa) Known function Accesion No Cellular Localization
Transport proteins
Porin 31HL (VDAC1) 30.7
(1) Transport of anions, cations, ATP, Ca
2+ and other metabolites
between mitochondria and cytosol. Potential role in protein
export from mitochondria.
gi|238427 OMM, plasma membrane,




(2) Nucleosome assembly gi|24638446 Nuclei
Histone H4* 11.3
(3) Nucleosome assembly gi|51315727 Nuclei
GST-hERK1 or GST-null recombinant proteins immobilized on GSH-agarose were incubated overnight with mitochondrial extracts. Beads were extensively washed and
eluted proteins run on PAGE-SDS. Proteins were stained with Coomasie Brilliant Blue G-250 (Fig. 2). A sample of each band in the GST-hERK1 or GST-null lane was
excised and analyzed by mass spectrometry for protein identification. Only proteins present in GST-hERK but not in GST-null precipitates were considered as specific
ERK partners. *Also confirmed by LC-MS/MS.
(#)Numbers in superscript correspond to the numbering of protein bands in Fig. 2. Only ERK interaction partners that were
extensively corroborated by further experiments are shown. For the totality of ERK interaction partners recovered after GST-hERK1 pulldown and MALDI-TOF
identification refer to supplemental Table S2 and Supporting Information S1.
doi:10.1371/journal.pone.0007541.t001
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PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7541Figure 3. ERK interaction with VDAC. (A) HeLa cells transfected with hERK1-GFP, fixed and labelled against VDAC. Secondary antibody was
conjugated with Cy3. The GFP and Cy3 images prior and after Cy3 photobleaching, the merged image of GFP and Cy3 prior to photobleaching and a
FRET map according to Eq. 1 are shown. Bar=10 mm. Color bar=FRET efficiency. Negative control: the same FRET experiment in HeLa cells
transfected with GFP and further stained against VDAC as above. Representative images shown on the right. (B) HeLa cells fixed and stained with
antibodies to phospho-ERK and VDAC. Secondary antibodies conjugated to Cy5 and Cy3, respectively. Cy3 and Cy5 images prior and after Cy5
photobleaching, a merged image of Cy3 and Cy5 prior to photobleaching and a FRET map in accord to Eq. 1 are shown. Bar=10 mm. Color bar=FRET
efficiency. Negative control: HeLa cells labelled against VDAC with both secondary antibodies; image series shown on the right. (C) Colocalization
indexes estimated for HeLa cells transfected with hERK1-GFP and labelled for VDAC as in (A). M and C coefficients were estimated for both green and
red channel images (Mgreen,M red,C green,C red). P=Pearson’s correlation coefficient, MO=Manders Overlap Coefficient. (D) Mean FRET efficiency in
HeLa cells transfected with hERK1-GFP and labelled for VDAC as in (A) in accord to Eq. 1. Negative controls: HeLa cells transfected with GFP and
labelled against VDAC plus Cy3 for specificity (light grey bars) and HeLa cells transfected with hERK1-GFP and no further staining for a FRET negative
value (black bars); *p,0.5 with respect to GFP transfected cells. (E) Mean FRET efficiency in HeLa cells labelled for phospho-ERK and VDAC plus Cy5
and Cy3, respectively, in accordance with Eq. 1. Negative controls: HeLa cells labelled with antibody to VDAC plus both secondary antibodies for
specificity (white bars); *p,0.5 with respect to negative control (Student’s t test).
doi:10.1371/journal.pone.0007541.g003
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PLoS ONE | www.plosone.org 6 October 2009 | Volume 4 | Issue 10 | e7541pulldown experiments under high stringency conditions and
electrophoresis in the absence of b-ME or DTT, a high molecular
weight band (MW ,130; Fig. 6A) was detected and identified as a
dimer of GST-hERK1 by MALDI-TOF-MS. This band was
disrupted after treatment with b-ME: in figure 6B, the high
molecular weight band corresponding to hERK1-GST dimer (left
lane) disappeared after b-ME treatment (right lane). This result
suggests the presence of a disulfide bridge between the two
monomers. The latter would involve ERK cysteines rather than
GST residues since we recovered endogenous ERK after
Figure 4. hERK1 interaction with histones. (A) HeLa cells transfected with hERK1-GFP, fixed and labelled with antibodies to H2A and H4 and a
secondary antibody conjugated with Cy3. GFP and Cy3 images prior and after Cy3 photobleaching, a merged image of GFP and Cy3 prior to
photobleaching and a FRET map in accord to Eq. 1 are shown. Bar=10 mm. Color bar=FRET efficiency. Negative control: same FRET experiment in
HeLa cells transfected with GFP and further stained against histones as above. Representative images are shown. (B) Colocalization indexes. M and C
coefficients were estimated for both green and red images (Mgreen,M red,C green,C red). P=Pearson’s correlation coefficient, MO=Manders Overlap
Coefficient. (C) Mean FRET efficiency estimated and analyzed as in Fig. 3; *p,0.5 with respect to GFP transfected cells. 1p,0.5 with respect to hERK1-
GFP transfected cells with no histone or Cy3 staining. (D) Pulldown experiment performed as in Fig. 2, with proteins detected by western blotting.
doi:10.1371/journal.pone.0007541.g004
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PLoS ONE | www.plosone.org 7 October 2009 | Volume 4 | Issue 10 | e7541Figure 5. Endogenous ERK1/2 interaction with histones. HeLa cells fixed and stained against phospho-ERK and histones. Secondary antibodies
conjugated to Cy3 and Cy5 respectively. Cy3 and Cy5 images prior and after Cy5 photobleaching, a merge image of Cy3 and Cy5 prior to
photobleaching and a FRET map in accordance with Eq. 1 are shown. Bar=10 mm. Color bar=FRET efficiency. Control for specificity of ERK-histones
interaction: HeLa cells labelled with antibody to phospho-ERK and both secondary antibodies (PERK); representative images are shown. Negative
FRET control: HeLa cells labelled for phospho-ERK and secondary Cy3 antibody (CN). Mean FRET efficiency shown in the bar graph on the upper right
side; *p,0.5 respect to negative control and 1p,0.5 with respect to specificity control (ANOVA and Scheffe ´ test).
doi:10.1371/journal.pone.0007541.g005
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PLoS ONE | www.plosone.org 8 October 2009 | Volume 4 | Issue 10 | e7541Figure 6. ERK dimer formation in mitochondria. (A) Pulldown assay and electrophoresis as in Fig. 2. Samples were run in the absence of b-ME or
DTT. Molecular weight markers displayed on the right. Thick arrow, GST-hERK1 dimer. (B) Recombinant hERK1-GST immobilized on GSH-agarose
incubated with mitochondria with dimerization evaluated by western blotting in the presence or absence of b2ME. Thin arrow, endogenous ERK,
recovered from the dimer upon incubation with b2ME. (C) hERK1-GST recombinant protein immobilized on GSH-agarose and incubated with
mitochondrial, cytosolic or nuclear fractions. hERK1-GST and hERK1-GST dimer detected by western blot. (D) GST-hERK1 recombinant protein
oxidized with different H2O2 concentrations and processed as in (C). Dimerization evaluated by western blotting. (E) Alignment of ERK1 (top) and
ERK2 (bottom) amino acid sequences. CD domain (yellow), ED domain (grey), dimerization site (green) [34,35], cysteines (purple) and cysteines (*)
putatively involved in disulfide bond formation are highlighted.
doi:10.1371/journal.pone.0007541.g006
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arrow), indicating that endogenous ERK is also able to form a
covalent dimer.
We investigated whether all the cellular fractions were capable
of enabling ERK dimerization by conducting comparative pull-
down experiments with mitochondrial, nuclear and cytosolic
extracts. GST-hERK1 dimerization was favoured in the mito-
chondria, also occurred in the nuclei, but was hardly detectable in
the cytosol (Fig. 6C). Inasmuch as the redox state of the cell
regulates kinase activity [12], we determined whether oxidation
could alter the dimerization capacity of hERK1. Oxidation
decreased the formation of the dimer (Fig. 6D), a result
attributable to the oxidation of cysteine residues to sulfonic acid
or other derivatives, reactions that would impede disulfide bridge
formation.
The cysteine residues involved in the bridge formation in hERK1
were identified by MALDI-ToF/ToF and ESI-LC-MSMS analysis
of the band corresponding to the dimer either in the presence or
absence of DTT. The off-line MALDI-ToF/ToF and ESI-LC-
MSMS experiments from the DTT treated samples reproducibly
revealed two peptides, positions 72 to 84 (KISPFEHQTYCQR)
and 166 to 189 (DLKPSNLLINTTCDLKICDFGLAR) in ERK1
that contain cysteines (Cys 82, 178 and 183). These two peptides
were not observed and thus were not sequenced in the non-DTT
treated sample. The results suggest that these protein regions may
be involved in forming disulfide bridges. We developed 6 mutants of
hERK1, changing each of the six cysteines present in the molecule
by alanine. All mutants were capable of dimerization (data not
shown), suggesting the participation of more than one cysteine in
disulfide bridge formation. It is noteworthy that both Cys 178 and
183 are embedded in the ERK ED domain involved in protein-
protein interactions between ERK and its kinases and substrates
(Fig. 6E) [34,35]. This domain also participates in homodimeriza-
tion. Further studies are needed to delineate the physiological
relevance of ERK dimerization occurring in mitochondria.
Regulation of mitochondrial gene expression
The ability of hERK1 to modulate mitochondrial transcription
was analyzed by microarrays, and both Real Time and
semiquantitative PCR experiments. Mitochondria from HeLa
cells were isolated and incubated with hERK1 for 1 h at 37uCi n
an import assay established for in organello RNA synthesis [36] (see
experimental procedures). mtRNA was further isolated and every
mitochondrial gene expression was evaluated as previously
mentioned. Almost every mitochondrial gene exhibited a tendency
for up regulation by treatment with hERK1. In contrast, the
mitochondrial rRNA genes showed a tendency for down
regulation. The available evidence raises the distinct possibility
that ERK exerts a modulatory role on mitochondrial gene
transcription (Fig. 7 and Table 2). The amino acid sequence of
mitochondrial transcription factor A (TFAM), contains a potential
ERK docking domain (Fig. S6) [32,33] and Ser 31, Ser 177 and
Thr 122 immersed in an ERK phosphorylation motif, suggesting
that ERK could bind and activate the transcription factor and
thereby regulate mitochondrial gene expression.
Discussion
To our knowledge, this is the first investigation exploiting a
functional proteomic strategy for systematically delineating
hERK1 signalling complexes in mitochondria. Using this
approach we have demonstrated the physical associations of
hERK1 with structural, signalling, transport and metabolic
proteins in the mitochondria of HeLa cells. Most of the proteins
found to be physically associated with ERK were not previously
known as interaction partners of this kinase.
We found that ERK interacts with histones, and confirmed the
presence of these nuclear proteins in the proximity of the OMM in
HeLa cells (Fig. S7). We performed a variety of contamination
controls to establish the integrity and purity of the mitochondrial
fraction (Fig. S1, Table S1 and Supporting Information S1).
Nonetheless, further research is required to ascertain the
physiological relevance of ERK-histone complexes in, on and
near mitochondria. Perhaps the best-characterized direct link
between signal transduction and chromatin modification is seen in
mammalian cells upon mitogen stimulation. H3 and other
chromatin-associated proteins, such as HMG14, are rapidly and
transiently phosphorylated in response to stimulation by epidermal
growth factor (EGF) [37]. Phosphorylation occurs at serine 10 of
the H3 N-terminal tail, and the time course of H3 phosphorylation
closely corresponds to the transient expression of activated
immediate-early genes, suggesting that this histone modification
is linked to transcriptional activation [reviewed in 37]. In the same
sense, phosphorylation of a yeast histone H2A at the C-terminal
serine 129 is of central importance in double-strand break repair.
Phosphorylation destabilizes chromatin structures and thereby
facilitates access of repair proteins [38]. Our findings support the
notion that histones H2A and H4 are bound to hERK1 in
mitochondria of HeLa. In the single previous study of histones in
mitochondria, Okamura et al. [39] reported that H1.2 is located in
mitochondria of SCCTF cells along with BAK. Furthermore,
Konishi et al. [40] suggested that H1.2 translocation from nuclei to
cytosol transduced the apoptogenic signals arising from DNA
damage to mitochondria, by causing cytochrome c release,
presumably by interaction with BAK. Our group have suggested
that mitochondria are common sites for phosphorylation of kinases
and other proteins [5,12]. Indeed, Poderoso et al. [5] have
demonstrated that there was an interaction between mitochondrial
StAR and ERK1/2, and as a result of this binding ERK1/2
phosphorylated StAR at Ser 232. Ser 2 in H2A, and Ser 2 and Ser
48 in H4 are embedded in an ERK phosphorylation motif [33]
and both histones also display putative ERK docking domains in
their amino acid sequences (Fig. S6) [32,33]. Thus, it is plausible
that ERK may phosphorylate these histones. An interesting
possibility is that phosphorylated H2A and H4 serve as ‘‘sensors’’
of available ATP and of normal electron transfer chain function
and coupling to oxidative phosphorylation, thereby constituting
informative molecules for activation of the cell cycle under
proliferative conditions (Fig. 8). ERK might also be phosphory-
lated in this region, and thus would dimerize and translocate to the
nucleus, possibly together with the histones.
We found that ERK also interacts with VDAC (Fig. 3), a
potentially significant finding inasmuch as VDAC1 features Ser
104 embedded in an ERK phosphorylation motif [31] and a
potential ERK docking domain (Fig. S6) [32,33]. Thus, ERK may
activate VDAC by phosphorylation. Activation of VDAC by other
MAPKs has been reported; p38 MAPK inhibition significantly
reduced the phosphorylation of VDAC1 in a rabbit model of
myocardial ischemia and reperfusion [41]. Further studies based
on these findings are required to assess the implications for the
regulation of cellular responses of ERK1 complexation with
histones and VDAC in the mitochondrial compartment.
Mitochondrial transcription factor A (TFAM) stimulates
mtDNA transcription in vitro, in vivo and in organello [42–44]. We
observed a tendency for upregulation of almost every mitochon-
drial gene by both microarray and Real Time PCR. However, we
failed to establish a statistical significance to these findings. TFAM
contains in its amino acid sequence a potential ERK docking
ERK1-Mitochondria Interaction
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immersed in an ERK phosphorylation motif. ERK moves in and
out mitochondria potentially through VDAC, and once in the
mitochondrial matrix it could associate with TFAM to activate
mtDNA transcription (Fig. 8).
We detected the formation of complexes of ERK1 with 2
enzymes of lipid metabolism: the fatty acid synthase (FAS) and the
hydroxyacyl-Coenzyme A dehydrogenase (HAD). ERK1 also
formed complexes with the b subunit of the mitochondrial ATP
synthase F1 complex and peroxiredoxin 3 (Prx3, Table S2).
Activation or inhibition of FAS and HAD may result in the
modulation of AcCoA mitochondrial concentration, which is a
potent regulator of mitochondrial oxidations. Further, we propose
that ERK may have a modulatory role on antioxidant enzymes
such as Prx3, as well as on ATPase, resulting in the regulation of
oxidative phosphorylation and thereby of superoxide anion and
mitochondrial H2O2 production (Fig. S8).
Galli et al. [12] showed that ERK1/2 exposure to low H2O2
concentration favoured the interaction with MEK, while higher
doses impeded this binding capacity. They also observed that two
cysteine residues in ERK2 structure were oxidized at the low
H2O2 concentration. Here we show that oxidation of ERK1
impairs dimerization (Fig. 6D), whereas association with mito-
chondria favours the formation of the dimer (Fig. 6C). Philipova
and Whitaker [18] argued that cofactors are required to achieve
the formation of ERK dimers in vitro. We suggest that if cofactors
are needed, they are best recruited in the proximity of
mitochondria. Native ERK forms dimers and high ERK kinase
activity is largely associated with biphosphodimers and not with
monophosphodimers or phosphorylated monomers [18]. If we
further consider that the OMM is enriched in ATP, and that non-
posphorylatable ERK2 mutants escape from this region with
slower kinetics [12], it follows that ERK phosphorylation and
dimerization may occur in this compartment, and that this process
may potentiate the translocation of the molecule to the nucleus
(Fig. 8). It has been demonstrated that residues P176-D179 and
Figure 7. ERK modulatory effect on mitochondrial gene
expression. Mitochondria from HeLa cells isolated and incubated
with hERK1 for 1 h at 37uCi na nin organello RNA synthesis assay (see
experimental procedures). mtRNA isolated and every mitochondrial
gene expression evaluated by (A) Real time PCR, or (B) Semiquantitative
PCR. GAPDH used as housekeeping gene. (C) Mitochondrial gene
expression also studied by microarray (see experimental procedures).
Mean fold-activation for every gene after ERK treatment of mitochon-
dria (See also Table 2). ND: NADH dehydrogenase; ATP: ATP synthase;
COX: cytochrome oxygenase. CYTB: cytochrome b. Number indicates
subunit.
doi:10.1371/journal.pone.0007541.g007
Table 2. Mitochondrial gene expression studied by microarray.
Mitochondrial gene Fold activation Significance Mean fold activation Mean6SD
ND1 0.5; 0.6; 0.7 0.0007; 0.0009; 0.04 0.460.3
ND2 0.6 0.0001 0.360.3
ND3 0.5 0.08 0.360.2
ND4 0.6 0.03 0.360.2
ND4L 0.6; 0.8; 1.5 0.002; 0.02; 0.006 0.660.5
ND5 0.7; 0.7; 0.8 0.000; 0.006; 0.04 0.560.4
ND6 - 1 0.260.3
ATP6 - 1 0.360.1
ATP8 - 1 0.0360.3
COX1 21.3; 21; 20.6 0.01; 0.0003; 0.002 20.760.4
COX2 0.5 0.001 0.360.2
COX3 - 1 0.0760.2
Cytochrome c -0.6; 0.9 0.1; 0.005 0.0760.5
12S RNA 20.9 0.05 20.260.4
16S RNA - 1 20.260.2
The microarray contained 6 different oligos per mitochondrial gene as described in Materials and Methods. The activation fold for each oligo was determined and
reported as Mean6SD. The fold-activation value is given only in cases with statistical significance, reported as p, tested as described in Materials and Methods and
deemed positive for values #0.05. Positive values correspond to an up regulation upon hERK1 treatment. ND: NADH dehydrogenase; ATP: ATP synthase; COX:
cytochrome oxygenase. Number denotes subunit.
doi:10.1371/journal.pone.0007541.t002
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ization [13]. Most of these residues are conserved in ERK1. We
and others [18] observed the formation of a covalent bond
between ERK1 molecules. How this phenomenon correlates with
the previous structural data remains to be elucidated.
From an evolutionary perspective, the structural and functional
interactions of ERK with mitochondrial proteins constitute
‘‘modern’’ events. Bacteria, the ancestors of mitochondria, have
a structurally and functionally diverse microbial kinome that
includes histidine kinases, protein kinases-like enzymes and
threonine kinases but not ERK1/2 or Akt [45]. Tyrosine kinases
(TK) and TK receptors appeared later in unicellular eukariotes
such as protists. The unicellular choanoflagellate Monosiga brevicollis
has already an elaborate TK signaling network, even more
complex than that of multicellular metazoans in which TK
represent key evolutionary factors for intercellular signalling [46].
Further specialization of kinomes in complex organisms like fungi,
nematodes or fly, arises in immunity, cell cycle modulation,
differentiation, neurogenesis or intercellular communication [47].
Recent studies confirmed that MAPKs are more ancient than
previously thought. ERK has been recognized in the protist
Dunaliella viridis [48], in yeasts [47] and in the parasite Entamoeba
histolytica [49]. ERK variants are present in insects, like Drosophila,
in reptiles and mammals. In yeast, ERK presents a peptide in the
C terminal tail, which is lost during evolution. This peptide leads
to ERK being continuously phosphorylated and thus devoid of the
regulation of modern ERK [50]. Modulation of ERK phosphor-
ylation is likewise associated with evolution to multicellular
organisms. In these and other publications [10,12] we propose
the existence of a mitochondrial ERK and phospho-ERK pool
which depend on cytosol ERK expression and on cell stimulation
by growth factors or stress, and argue that the phosphorylation
and redistribution of this kinase also depends on trafficking to/
from mitochondria. If so, the phenomenon would expand still
further the spatio-temporal network regulating signal transduction
effected by this key molecule [51].
In the present study we addressed the effects exerted by ERK1
on mitochondria of HeLa cells, as well as the potential roles of the
organelle in determining ERK availability for the remaining
cellular compartments. The results suggest novel, previously
unrecognized functions of ERK and provide an integrated
framework for defining and understanding novel ERK1 signalling




Human cervical carcinoma HeLa cells (obtained from Thomas
Tuschl’s laboratory, Department of Cellular Biochemistry, Max
Plank Institute for Biophysical Chemistry, Go ¨ttingen, Germany),
were cultured in D-MEM plus GlutaMAX
TM-1 (Gibco) with 10%
Figure 8. Postulated structural interactions of hERK1 with mitochondria. Scheme showing a new perspective for the physiological role of
hERK1 in relation to the regulation of cellular signalling and trafficking in HeLa cells. ERK1 may be a carriage protein that would facilitate histone
traffic to the ATP source in the surroundings of the OMM, and afterwards to the nuclei. Altogether this complex may interact with ERK transcription
factors and the transcription machinery to enhance RNA synthesis. ERK translocation into and out the mitochondria may occur via VDAC protein.
Once inside, the kinase may regulate mtDNA transcription by regulation of TFAM. I, II, III and IV: mitochondrial electron transport chain complexes,
Cyt: cytochrome c, ANT: ATP carrier. The model is simplified for H2A, but the same is proposed for H4.
doi:10.1371/journal.pone.0007541.g008
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medium was replaced twice per week. Passages were made by
trypsinization of confluent monolayers.
Constructs and recombinant proteins
hERK1-GFP was a gift of Diane Lidke. Human ERK1-
pcDNA3 cDNA was a gift of Dr. Jacques Pouyssegur. hERK1
was cloned into the EcoRI site of the bacterial expression vector
pGEX-4T-1 and transformed into E. coli BL21. Recombinant
GST-hERK1 protein was expressed and purified as described
[52] with some modifications. Briefly, 100 ml of overnight
culture was diluted 1:10 in a final volume of 1000 ml and
incubated for 1 h at 37uC with shaking; 0.1 mM isopropyl 8-D-
thiogalactoside was added, and the mixture was incubated
f u r t h e rf o r8h ra t3 7 uC with shaking. Bacteria were centrifuged
at 60006g for 5 min at 4uC. Pellets were lysed in 100 ml of
2 5m MT r i s - H C l ,p H7 . 7 ,1 0 0m MN a C l ,1m MD T T ,0 . 1 %
NP-40 and 20% glycerol plus protease inhibitors (Protease
inhibitor tablets, EDTA free, Roche). After 30 min on ice, cells
were sonicated and centrifuged at 17,2006g for 15 min at 4uC.
The supernatant was incubated with 1 ml of 50% v/v GSH-
agarose beads (Sigma) overnight at 4uCw i t hg e n t l er o c k i n g .T h e
beads were washed four times with 10 volumes of PBS. The
fusion protein was eluted with 3 volumes of 5 mM GSH, 50 mM
Tris-HCl, pH 8.0. Free GSH was removed by dialysis against
PBS. GST was removed from the recombinant protein with
thrombin. The purified recombinant protein identity was
corroborated by MALDI-TOF-MSa n db yw e s t e r nb l o tw i t h
specific antibodies and stored at 220uC.
hERK1-Dronpa was generated by cloning Dronpa (the kind gift
of A. Miyawaki) [53] in frame with the hERK1 sequence in the
hERK1-pcDNA3 vector.
Mitochondrial isolation
HeLa cells were lysed in MSHE buffer (0.22 M mannitol,
0.07 M sucrose, 0.5 mM EGTA, 2 mM HEPES-KOH, pH 7.4)
in the presence of protease inhibitors as above, and phosphatase
inhibitors (25 mM NaF, 1 mM sodium orthovanadate). The
homogenate was centrifuged for 10 min at 7006g. The superna-
tant was centrifuged at 70006g for 20 min, and the mitochondrial
pellet was washed once in 150 mM KCl, and once in MSHE. The
mitochondrial fraction was essentially free of other compartmental
contaminants (Fig. S1), as previously reported [54,55]. Washing
with 150 mM KCl depleted mitochondria of surrounding cytosolic
mRNAs. For the microarray experiments, cytosolic mRNAs were
needed for normalization and thus this washing step was omitted
from the purification procedure.
GST affinity pulldown assay
GST-based affinity pulldown assays were performed as
previously reported [56,57]. Briefly, 1 mg of GST-hERK1 or
GST-null recombinant protein was immobilized on GSH-agarose
beads, and incubated with 500 mg HeLa mitochondrial protein in
binding buffer (0.2% Triton X-100, 150 mM NaCl, 20 mM Tris-
HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.2 mM sodium
orthovanadate, and protease inhibitors as above), overnight at
4uC. GST-null protein was used as a negative control. The GST-
hERK1 or GST-null protein complexes were extensively washed
and resolved on SDS-PAGE. After colloidal Coomassie staining,
either gel plugs of 1.5 mm diameter or entire gel bands were
excised manually. A corresponding sample was excised from the
negative control lane and processed in parallel. Only proteins not
appearing in the negative control and found repeatedly in at least
2 pulldown experiments were considered as binding partners of
hERK1. Five independent pulldown assays were performed.
Protein identification
Manually excised gel plugs were subjected to an automated
platform for the identification of gel-separated proteins [58] as
described in the framework of recent large-scale proteome studies
[59,60]. An Ultraflex MALDI-TOF mass spectrometer (Bruker
Daltonics) was used to acquire both peptide mass fingerprint
(PMF) and fragment ion spectra, resulting in confident protein
identifications based on peptide mass and sequence information.
Database searches in the NCBI non-redundant primary sequence
database restricted to the taxonomy Homo sapiens were performed
using the Mascot Software 2.0 (Matrix Science) with parameter
settings described earlier [59,60]. The minimal requirement for
accepting a protein as identified was at least one peptide sequence
match above identity threshold in coincidence with at least four
peptide masses assigned in the PMF.
Nano-flow LC-MS/MS was used as a complementary approach
for protein identification, mainly to confirm the detection of
histones. Tryptic peptides were subjected to reversed phase
separation using 0.1% formic acid as solvent A and 0.1% formic
acid in 100% acetonitrile as solvent B. An Ultimate nano-HPLC
system (Dionex) consisting of an autosampler, a loading pump, and
a nano-HPLC gradient pump connected to a 75-mm-inner
diameter column (C18 PepMap, 15-cm length, 5-mm particle size,
and 100-A ˚ pore size) was utilized. Peptides were desalted and
concentrated on a 300-mm-inner diameter C18 PepMap column of
1 mm length at a flow rate of 25 ml/min. Separation was
performed with a flow rate of 250 nl/min using a binary gradient
starting at 5% solvent B rising to 60% in 50 min. Peptides were
directly eluted into an ESI ion trap LCQ Deca XP Plus mass
spectrometer (Thermo) with the acquisition duty cycle set to a full
scan mass spectrum (m/z 400–1500) followed by two data-
dependent MS/MS scans. Mascot data base searches were
performed as for the MALDI-TOF-MS data but the mass
tolerance was 1.5 Da for the precursor ions and 1.0 Da for the
fragment ions. The protein was considered identified when at least
two peptide sequence matches above identity threshold were
present.
Disulfide bridge mapping
Gel bands were digested according to Shevchenko et al. [61] in
the presence or absence of DTT. Dissolved samples were injected
on an Ultimate gradient LC-System (LC Packings) equipped with
pre-columns (2560.075 mm packed in-house, C18, 5 mm, 300A
(Vydac, Hesperia, USA)) working in back-flush mode. Peptides
were separated with a standard gradient using 0.1% TFA in water
as solvent A and 80% acetonitrile (v/v) in 0.1% TFA as solvent B,
at a 300 nL/min flow rate on an analytical column
(20060.75 mm, C18, 5 mm, 300A (Vydac, Hesperia, USA)). The
eluate was mixed with 10 mg/mL-cyano-4-hydroxycinnamic acid
containing 10 fmol/ml Glu-Fibrinogen (Sigma) as internal stan-
dard in 70% acetonitrile, 0.1% TFA and spotted (Probot, LC
Packings) every 15 sec onto an ABI stainless-steel target (Applied
Biosystems). MALDI-ToF/ToF analysis was carried out in a 4800
Analyzer (Applied Biosystems/MDS Sciex) in positive mode. For
MS experiments, 800 laser shots were accumulated, and for MS/
MS max. 2000 laser shots were accumulated for each precursor.
The acceleration voltage was 1 kV and collision energy was set to
10
-6 torr. Proteins were identified as above. Two missed cleavages
and oxidation and carbamylation as variable modifications were
allowed for in the search. Mass deviation was 100 ppm for MS
and 400 mmu for MS/MS.
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Agilent 1100 chromatography system equipped with a pre-column
(2560.75 mm, C18, 5 mm, 120 A, Maisch, Munich, Germany) in
line with the analytical column (25060.075 mm, C18, 5 mm, 120
A, Maisch, Munich, Germany). Eluting peptides were sprayed into
an Orbitrap XL mass spectrometer working in CID mode under
standard conditions.
Mitochondrial protein import assay and in organello RNA
synthesis
The mitochondrial import assay was performed according to
Komiya and Mihara [62] with modifications. Briefly, 200 mgo f
mitochondrial proteins were incubated in 10 mM MOPS-NaOH,
2.5 mM phosphate-NaOH, pH 7.2, 250 mM sucrose, 5 mM
MgCl2, 80 mM KCl, 2 mM ATP, 1% BSA, 1.42 mg/ml NADH
plus 1 mg hERK1, at 37uC, for 1 h. Samples were then washed
and run on SDS-PAGE. When mitochondrial gene expression was
being assessed, ATP was substituted by 1 mM ADP, and NADH
by 10 mM glutamate and 2.5 mM malate [36]. After treatment,
mitochondria were washed and resuspended in Trizol (Invitrogen)
for RNA isolation.
Fluorescence labeling and confocal microscopy
Cells were grown on Lab-Tek Chambered Borosilicate Cover-
glass System (Nunc) for in vivo experiments, or on coverslides when
cells were further fixed and immuno-stained, and transfected with
hERK1-GFP or hERK1-Dronpa using Lipofectamine 2000
(Invitrogen) according to manufacturer’s instructions. Cells were
stained with specific mitochondrial markers, MitoTracker RED
CMXRos or MitoTracker Deep Red (Invitrogen) (100 nM,
45 min at 37uC), fixed in 4% paraformaldehyde, permeabilized
and labelled against phospho-ERK1/2, histones or VDAC in
10 mM Tris-HCl, pH 7.0, 1% BSA, 0.05% Triton X-100.
Secondary antibodies were conjugated with Cy3 or Cy5. When
appropriate, labelled coverslides were washed in 0.1% Triton
X-100 in PBS for 1 h under stirring previous to montage.
Isolated mitochondria were labelled with MitoTracker Deep
Red (Invitrogen) (100 nM, 45 min at 37uC), fixed in 4%
paraformaldehyde, permeabilized and labelled against phospho-
ERK1/2 and a secondary antibody conjugated to Cy3 as above.
Images of cells transfected with hERK-GFP and labeled for
histones or VDAC plus Cy3 were acquired in a Zeiss LSM 510-
meta confocal laser scanning microscope using a 6361.2 NA water
immersion objective. Excitation and emission filters were as
follows: GFP, 488 nm excitation, BP 520612 nm emission; Cy3,
532 nm excitation, LP 585 nm emission. FRET was performed by
acceptor photobleaching [63]. The FRET pair was GFP and Cy3.
Cy3 fluorescence was bleached up to 70% by 200 interactions of
532 nm laser at maximum power. No bleaching of GFP was
detected under this condition. Negative controls for FRET were
performed on cells transfected with hERK1-GFP without
antibodies and Cy3 labelling. An additional control for the
specificity of the interaction was performed with cells transfected
with GFP and further labelled against histones or VDAC and the






where Impre and Impos were GFP images before and after Cy3
photobleaching.
Other images were acquired with an Olympus FV-1000
confocal microscope using a 6061.35 NA oil immersion objective.
Excitation and filters were as follows: GFP, 488 nm excitation, BP
500–530 nm emission; MitoTracker RED CMXRos and Cy3,
543 nm excitation, BP 555–655 nm emission; MitoTracker Deep
Red and Cy5, 633 nm excitation, BP 655–755 nm emission.
Images were acquired in a sequential mode. No channel cross-talk
was observed.
Endogenous phospho-ERK1/2 and histones or VDAC inter-
action was accomplished by FRET. In this case, we used Cy3/Cy5
as the fluorophore pair. Cy5 fluorescence was bleached up to 70%
by 50 interactions of 633 nm laser at maximum power. No
bleaching of Cy3 was detected in this condition. Negative controls
were performed on cells labelled against phospho-ERK1/2 plus
Cy3 and Cy5 for specificity, or only with Cy3 for a negative FRET
value; or against VDAC plus Cy3 and Cy5 for specificity, and only
with Cy3 for a negative FRET value. FRET was determined as
Eq. 1; Impre and Impos were Cy3 images before and after Cy5
photobleaching.
Image analysis
The image and statistical analyses were performed with Matlab
(MathWorks, Natick, MA) and DIPimage (image processing
toolbox for Matlab, Delft University of Technology, The Nether-
lands). Background levels were obtained by measuring the mean
intensity of each signal outside the cells and were subtracted.
Negative pixel values were clipped to zero.
To evaluate hERK1-GFP redistribution among the subcellular
compartments of HeLa cells mitochondrial masks were generated
from the MitoTracker fluorescence; nuclear masks were generated
manually, and cellular masks of transfected cells were obtained
using the GFP fluorescence. Further details of these procedures are
supplied in the supporting online material (Fig. S9 and Supporting
Information S1). hERK1-GFP fluorescence intensity was quanti-
fied in each compartment and normalized by the mean intensity
of the whole cell or group of cells imaged simultaneously. Manders
colocalization indexes, Manders Overlap Coefficient, and Pear-
son’s correlation coefficient were calculated as previously
described [64] (see also supporting online material).
The evaluation of phospho-ERK-Cy3 fluorescence intensity in
isolated mitochondria was performed using a mask based on
MitoTracker Deep Red fluorescence and the Cy3 signal within the
mask.
FRET maps were generated using Eq. 1. The mean FRET
efficiency within a mask was calculated using pixels with GFP (for
the GFP/Cy3 FRET pairs) or Cy3 (for the Cy3/Cy5 FRET pairs)
intensities exceeding the mean values of the entire image. Values
were generated for every individual cell present in a given image
and means were calculated from all the cells in all the images.
Flow cytometry
Isolated mitochondria were fixed in 4% paraformaldehyde,
permeabilized and labelled against histones in 10 mM Tris-HCl,
pH 7.0, 1% BSA, 0.05% Triton X-100 or directly labelled without
fixation and permeabilization in 10 mM Tris-HCl, pH 7.0, 1%
BSA. Secondary antibody was conjugated with Cy5. Negative
controls were performed by labelling only with secondary
antibody. Mitochondria were analyzed on a Beckman Coulter
Epics Elite flow cytometer.
Western blot
Mitochondrial proteins and recombinant purified proteins were
resolved on 10–12% SDS-PAGE gels (Invitrogen) and transferred
onto nitrocellulose membranes. After blocking with 5% non-fat
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pH 7.4), the membranes were incubated with the proper primary
(phospho-ERK from Cell Signaling, VDAC from Calbiochem,
GAPDH from Santa Cruz, histones from Upstate and Complex I
subunit from Molecular Probes) and secondary antibodies and
detected with SuperSignal West Pico Chemiluminiscent Substrate
(Pierce Biotechnology) with a Fujifilm LAS-1000 CCD camera.
Microarray
Samples were DNAse I treated. RNA quality was determined
using the Agilent 2100 Bioanalyzer (Agilent Technologies). The
samples for hybridization were prepared from 0.75 mg of total
RNA according to the Atlas SMART Fluorescent Probe
Amplification Kit protocol (Clontech-Takara Bio Europe), except
that (i) the RNA template was hydrolyzed under alkaline
conditions before cDNA purification, and (ii) the PCR amplifica-
tion process was monitored and terminated in the exponential
phase. Quantity and dye incorporation rates of the converted
RNA were assessed using a NanoDrop ND-100. Per microarray,
0.8 mg of Cy3 and Cy5 labelled cDNA fragments, respectively,
were hybridized to Agilent Technologies 2611K Custom Micro-
arrays for 17 h at 63uC. The microarrays were designed via
Agilent eArray and included 90 oligonucleotides for all known
human mtRNAs (6 oligos for each gene). The rest of the DNA-
chips were filled with selected genes from the human genome and
were used for normalization. Post processing washes were
performed according to the Agilent Technologies SSPE protocol
(v2.1), replacing wash solution 3 by acetonitrile, followed by
immediate scanning using an Agilent G2505B scanner. Intensity
data were extracted with Agilent’s Feature Extraction 9.5 software.
The oligos to map the mitochondrial genes were selected as
follows: (i) more than one sequence was selected per gene; (ii)
stretches of repeating oligonucleotides were avoided; (iii) a
balanced AT and GC content was preferred; (iv) sense and
antisense strands were considered; and (v) all sequences were
blasted against GenBank database to check for cross hybridisation.
Three oligos were selected (from the 59-end, the middle and the 39-
end) of each mitochondrial gene sequence and translated into
antisense. This procedure yielded six oligos per gene.
The raw intensity data were normalized with a non-linear
lowess regression [65,66]. Differentially expressed genes were
identified by an ANOVA fixed effects model [67]. Adjusted
p-values were obtained by the Benjamini-Hochberg method to
control the false-discovery-rate [68].
The microarray data were generated conforming to the
MIAME guidelines and deposited in the Gene Expression
Omnibus (GEO) database at http://www.ncbi.nlm.nih.gov/geo/
(accession number GSE14963).
Real Time PCR
cDNA was obtained as described above. Real Time PCR was
performed with iQ SYBR Green supermix (Bio-Rad) in a iQ5
iCycler (BioRad) according to the manufacturer’s instructions.
Primers for each gene were either newly designed or taken from
the Real Time PCR primer and probe Database (RTPrimerDB;
http://medgen.urgent.be/rtprimerdb/) (Table S3). SemiQuanti-
tative PCR was performed with One Step RT-PCR kit (Qiagen).
Calibration curves were performed as described by manufacturer
instructions. Efficiency accounted for more than 90%.
Statistical analysis
Data are expressed as means6SE and analysed by one-way
analysis of variance (ANOVA) and Scheffe ´ test or the Student’s t
test. Statistical significance was accepted at p,0.05. hERK1-GFP
redistribution upon FCS stimulation was evaluated in three image
sequences. Redistribution with no stimulation was studied in one
image sequence. hERK1-GFP localization to mitochondria in
non-serum starved HeLa cells was determined in 6 images.
Endogenous presence of ERK1/2 in mitochondria of HeLa cells
was evaluated once by confocal microscopy and a minimum of
twice by western blotting. The import assays based on western
blotting was performed twice. The import assays for RNA
isolation and semiquantitative PCR were performed at least three
times and twice for Real Time. The FRET determination with
hERK-GFP and histones or VDAC labelled with Cy3 was
performed once; five images were taken and analysed for each
interaction. The FRET measurements of endogenous phospho-
ERK1/2 and histones or VDAC were repeated twice; .10 images
were acquired and analysed for each interaction. The mean FRET
values in each cell of a given image were determined and
averaged. ERK dimer dissociation by b-ME was conducted three
times with similar results. ERK dimer formation in the different
subcellular compartments and the influence of oxidation were
performed at least twice. The microarray determination was
conducted once.
Supporting Information
Supporting Information S1 This file contains supplementary
results, methods, tables and references.
Found at: doi:10.1371/journal.pone.0007541.s001 (0.05 MB
DOC)
Figure S1 Identity and purity of mitochondrial fraction. Isolated
mitochondria, cytosol, and nuclei were analysed to check for
contamination. (A) Mitochondrial, nuclear and cytosolic fractions
were labelled with MitoTracker Deep Red and analysed on a flow
cytometer. Fluorescence intensity in arbitrary units. (B) Western
blot of the same fractions with antibodies for characteristic
proteins of mitochondria (Complex I) and cytosol (GAPDH). (C)
DNA was extracted from mitochondria or whole cells and specific
nuclear (GAPDH, Actin) and mitochondrial (ND1, ATP6) genes
were detected by PCR. (D) RNA extracted from mitochondria
(lower profile) or whole cell (upper profile) was DNAsed and
analyzed on an Agilent 2100 Bioanalyzer microfluide electropho-
resis. Peak profile of different size RNAs displayed on the right;
corresponding generated band pattern of the RNA on the left.
Nt=nucleotide, FU=Fluorescence Units.
Found at: doi:10.1371/journal.pone.0007541.s002 (1.16 MB TIF)
Figure S2 hERK1 presence in mitochondria is dependent on
cell condition. HeLa cells were transfected with hERK1-GFP,
24 h FCS starved or continuously grown in 10% FCS, and stained
with MitoTracker CMXRos. Fluorescence intensity of both green
(GFP) and red (MitoTracker) channels was analyzed in an
Olympus FV1000 confocal microscope. Representative images
of both channels separated and merged are shown. Bar=10 mum.
Yellow arrows indicate pixels that display MitoTracker fluores-
cence intensity but little or no GFP fluorescence intensity. Orange
arrows indicate pixels that display both MitoTracker fluorescence
and GFP fluorescence intensity.
Found at: doi:10.1371/journal.pone.0007541.s003 (2.00 MB TIF)
Figure S3 Presence and translocation of hERK1 into mito-
chondria. (A) HeLa cells were transfected with hERK1-GFP, 24 h
FCS starved and stained with MitoTracker CMXRos. Fluores-
cence intensity of both green (GFP) and red (Mitotracker) channels
was followed for 20 min in an Olympus FV1000 confocal
microscope without FCS stimulation of cells. Images of three
representative time points of the individual and merged channels is
ERK1-Mitochondria Interaction
PLoS ONE | www.plosone.org 15 October 2009 | Volume 4 | Issue 10 | e7541shown. Bar=10 mm. (B) Graph showing the redistribution of
hERK1-GFP fluorescence intensity in the different cellular
compartments in the absence of stimulus. (C) Change in
hERK1-GFP fluorescence intensity in time analysed in mitochon-
dria, nuclei and cytosol for each of the 3 confocal planes of the pair
of images in A. Graphs show the net change displayed as
percentage of the initial value (% of control) in each compartment
in the absence of FCS stimulation. (D) Change in Pearson’s
correlation coefficient after FCS stimulation of serum starved cells
analysed within the mitochondrial mask. (E) Zoom of the images
in (A). Orange arrows indicate pixels that display both Mito-
Tracker fluorescence and GFP fluorescence intensity.
Found at: doi:10.1371/journal.pone.0007541.s004 (1.94 MB TIF)
Figure S4 Presence and translocation of GFP into mitochondria.
(A) HeLa cells were transfected with GFP, serum starved for 24 h,
and stained with MitoTracker Deep Red. Fluorescence intensity of
both green (GFP) and red (Mitotracker) channels was followed for
10 min in an Olympus FV1000 confocal microscope upon 5%
FCS stimulation of cells. Images of four representative time points
of the individual and merged channels are shown. Bar=10 mm.
(B) Progress of hERK1-GFP fluorescence intensity in time
analysed in mitochondria, nuclei and cytosol for each of the 3
confocal planes of the pair of images in A. Graphs show the net
change displayed as the mean GFP fluorescence intensity of each
compartment normalized by the mean GFP fluorescence of the
cell.
Found at: doi:10.1371/journal.pone.0007541.s005 (1.41 MB TIF)
Figure S5 Statistical analysis of hERK1 localization to mito-
chondria. Analysis was performed on the first pair of images of
Fig. 1A. The probability distribution of random colocalization was
obtained by computing the Pearson’s correlation coefficient after
repetitively scrambling the pixel positions in the green hERK1-
GFP image. Red line=normal distribution adjusted to the data.
The Pearson’s correlation coefficient (P) of the original image is
displayed in the inset and is far beyond the value in which the
probability density curve equals 96% [21].
Found at: doi:10.1371/journal.pone.0007541.s006 (0.53 MB
DOC)
Figure S6 ERK docking sites. Potential ERK docking domains
present in the ERK interactor partners. The N-terminal
hydrophobic residue (green), the positively charged residues (blue),
and the hydrophobic -X- hydrophobic motif (red) in the D motifs
are indicated in accord to [32]. In bold, alternative consensus
motif. Serine immersed in a phosphorylation consensus motif for
ERK in TFAM sequence indicated in the box.
Found at: doi:10.1371/journal.pone.0007541.s007 (0.49 MB
DOC)
Figure S7 Histone recovery in the mitochondrial fraction. (A)
Mitochondria of HeLa cells either fixed and permeabilized
(medium panels), or without fixation and permeabilization (right
panels) were labelled against histones and analysed by flow
cytometry. Whole cells were fixed, permeabilized and labelled as a
positive control (left panels). (B) Pure mitochondria were incubated
with proteinase K, with or without Triton X-100 to permeabilize
the organelle. Histones were recovered by acidic extraction and
evaluated by western blot.
Found at: doi:10.1371/journal.pone.0007541.s008 (0.71 MB
DOC)
Figure S8 Proposed metabolic effects of ERK1 in mitochondria.
In red, interaction confirmed by proteomics; in yellow, acetylated
components; MTFA, mitochondrial transcription factor, FFA, free
fatty acids.
Found at: doi:10.1371/journal.pone.0007541.s009 (0.55 MB
DOC)
Figure S9 Image analysis. (A) HeLa cells transfected with
hERK1-GFP and stained with MitoTracker CMXRos.
Bar=10 mm. (B) Histogram of fluorescence intensity vs. number
of pixels for both green (left) and red (right) channel images. Arrow
indicates mean fluorescence intensity, also shown in the inset. (C)
Mitochondrial compartment mask selected when MitoTracker
fluorescence intensity was above twice the mean of the whole red
image (upper right panel). The cellular compartment mask
delimited when GFP fluorescence intensity was over the mean
fluorescence intensity of the whole green image (upper left panel).
Nuclear masks were determined manually (lower left panel).
hERK1-GFP kinetics was studied only in mitochondria of
transfected cells, and thus a new mask was determined by the
combination of both the cellular mask and the Mitoctracker
generated mask (lower right panel).
Found at: doi:10.1371/journal.pone.0007541.s010 (0.78 MB TIF)
Table S1 Contamination indexes. 59 nucleotidase and glucose-
6-phosphatase were determined in mitochondria from HeLa cells
and compared with existing data from the literature to asses for the
contamination index of this fraction with endoplasmic reticulum.
*A Percoll gradient was not used in the purification of
mitochondria. ND: not determined. Data are mean6SD.
Found at: doi:10.1371/journal.pone.0007541.s011 (0.03 MB
DOC)
Table S2 hERK1 signaling complexes in mitochondria from
HeLa cells. GST-hERK1 or GST-null recombinant proteins
immobilized on GSH-agarose were incubated overnight with
mitochondrial extract. Beads were extensively washed and eluted
proteins run on PAGE-SDS. Proteins were stained with Coomasie
Brilliant Blue G-250 (Fig. 2). A sample of each band in the GST-
hERK1 or GST-null lane was excised and analysed by mass
spectrometry for protein identification. Only proteins present in
GST-hERK but not in GST-null precipitates were considered as
specific ERK partners. These ERK interaction partners were
indentified in at least 2 pull down experiments followed by
MALDI-TOF-MS analysis.
Found at: doi:10.1371/journal.pone.0007541.s012 (0.04 MB
DOC)
Table S3 Real Time PCR primer pairs. ND: NADH dehydro-
genase; ATP: ATP synthase; COX: cytochrome oxigenase;
CYTB: cytochrome b. Number accounts for subunit. Primers
were either newly designed (New) or extracted from the Real Time
PCR primer Data Bank (RTPrimerDB)(http://medgen.urgent.
be/rtprimerdb/).
Found at: doi:10.1371/journal.pone.0007541.s013 (0.03 MB
DOC)
Movie S1 Presence and translocation of hERK1 into mitochon-
dria upon FCS stimulation. HeLa cells were transfected with GFP-
hERK1, 24 h FCS starved and stained with MitoTracker
CMXRos. Fluorescence intensity of both green (GFP) and red
(Mitotracker) channels was followed for 20 min in an Olympus
FV1000 confocal microscope after FCS stimulation of cells.
Images were acquired every one minute.
Found at: doi:10.1371/journal.pone.0007541.s014 (15.73 MB
AVI)
Movie S2 Presence and translocation of hERK1 into mitochon-
dria without stimulation. Same as in Movie S1 but without FCS
stimulation of cells.
Found at: doi:10.1371/journal.pone.0007541.s015 (7.87 MB AVI)
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